Selected article for: "cell culture and safety profile"

Author: Vere Hodge, R Anthony
Title: Meeting report: 30th International Conference on Antiviral Research, in Atlanta, GA, USA
  • Document date: 2018_6_28
  • ID: tudwns0r_61
    Snippet: The Polio Antivirals Initiative was set up with the aim to select promising candidate compounds and seek sponsors to progress these compounds. Just two compounds, pocapavir (V-073, capsid inhibitor, preventing viral RNA release) and V-7404 (3C protease inhibitor (PI)), have been identified as having the potential to be progressed quickly. Both these compounds have known cell culture activity against poliovirus, preclinical bioavailability and saf.....
    Document: The Polio Antivirals Initiative was set up with the aim to select promising candidate compounds and seek sponsors to progress these compounds. Just two compounds, pocapavir (V-073, capsid inhibitor, preventing viral RNA release) and V-7404 (3C protease inhibitor (PI)), have been identified as having the potential to be progressed quickly. Both these compounds have known cell culture activity against poliovirus, preclinical bioavailability and safety profile data.

    Search related documents:
    Co phrase search for related documents
    • candidate compound and promising candidate compound: 1, 2, 3, 4, 5, 6
    • candidate compound and protease inhibitor: 1, 2, 3
    • candidate compound and RNA release: 1
    • candidate compound and viral RNA release: 1
    • capsid inhibitor and protease inhibitor: 1, 2
    • capsid inhibitor and RNA release: 1
    • capsid inhibitor and safety profile: 1
    • capsid inhibitor and viral RNA release: 1
    • cell culture activity and protease inhibitor: 1, 2
    • cell culture activity and RNA release: 1
    • cell culture and protease inhibitor: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36
    • cell culture and RNA release: 1, 2
    • cell culture and safety profile: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
    • cell culture and viral RNA release: 1
    • protease inhibitor and RNA release: 1
    • protease inhibitor and safety profile: 1, 2, 3, 4, 5
    • protease inhibitor and viral RNA release: 1